Interleukin 2 (IL-2) is the only systemic treatment currently available that is capable of curing patients with metastatic renal cell cancer (RCC). The first indications that IL-2 could mediate ...

People with RCC have various treatment options ... Medical News Today has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals ...

Reflecting the growing understanding of rosacea as a continuum of systemic inflammation, new National Rosacea Society (NRS) Treatment Algorithms suggest therapies based not on the rosacea subtype ...